Movement disorders in 2024: peripheral and outside the box.

Lancet Neurol

Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Biomedical Engineering, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan; Graduate Institute of Molecular Medicine, and Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan.

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(24)00487-3DOI Listing

Publication Analysis

Top Keywords

movement disorders
4
disorders 2024
4
2024 peripheral
4
peripheral box
4
movement
1
0
1
peripheral
1
box
1

Similar Publications

Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders.

Pharmacol Rep

December 2024

Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology (CEPT), Medical University of Warsaw, Banacha 1B, Warszawa, 02-097, Poland.

Sudden cessation of the drug can cause withdrawal syndrome, discontinuation syndrome, or rebound effect. The common feature of these phenomena is a quick onset, usually limited duration depending on the drug's half-life and remission after restarting the therapy. They are characterized by varying clusters of somatic, autonomic, and psychiatric symptoms.

View Article and Find Full Text PDF

Dura immunity configures leptomeningeal metastasis immunosuppression for cerebrospinal fluid barrier invasion.

Nat Cancer

December 2024

Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.

The cerebrospinal fluid (CSF) border accommodates diverse immune cells that permit peripheral cell immunosurveillance. However, the intricate interactions between CSF immune cells and infiltrating cancer cells remain poorly understood. Here we use fate mapping, longitudinal time-lapse imaging and multiomics technologies to investigate the precise origin, cellular crosstalk and molecular landscape of macrophages that contribute to leptomeningeal metastasis (LM) progression.

View Article and Find Full Text PDF

[How to use clinical neurophysiology in functional neurological disorders (FND)?].

Rinsho Shinkeigaku

December 2024

Section of Human Neurophysiology, Institute of Biomedical Sciences, Fukushima Medical University.

I have reviewed the utility of clinical neurophysiological examinations in recently highlighted functional neurological disorders (FND) focusing mainly on functional movement disorders (FMD). There are many neurophysiological methods useful for diagnosis of FMD. I will hereafter summarize a few of them in the following part.

View Article and Find Full Text PDF

Effects of age/gender profiles and physical activity level on symmetry of lumbar muscle activation in pain-free older adults during various spinal movements.

Gait Posture

December 2024

Department of Orthopedic Surgery, Division of Orthopedic Research, Mayo Clinic, Rochester, MN, USA. Electronic address:

Background: Back muscles simultaneously drive spinal movements and stabilize the trunk. Paraspinal muscle activity is presumed to be symmetric and gender-insensitive, and more activated with aging to protect the spine during functional tasks.

Research Question: Does over-activated and asymmetric behaviors exist in the pain-free elderly population which is affected by their physical activity levels?

Methods: Forty healthy participants (aged 64.

View Article and Find Full Text PDF

Mitochondrial dysfunction and α-synuclein (αSyn) aggregation are key contributors to Parkinson's Disease (PD). While genetic and environmental risk factors, including mutations in mitochondrial-associated genes, are implicated in PD, the precise mechanisms linking mitochondrial defects to αSyn pathology remain incompletely understood, hindering the development of effective therapeutic interventions. Here, we identify the loss of branched chain ketoacid dehydrogenase kinase (BCKDK) as a mitochondrial risk factor that exacerbates αSyn pathology by disrupting Complex I function.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!